Bison Capital Structured Equity Partners, LLC announces sale of its investment in Metagenics, Inc.
Los Angeles, CA – September 11, 2009 – Bison Capital announced that it has sold its security holdings in Metagenics, Inc, the leading manufacturer and distributor of science-based medical foods and nutraceuticals to licensed healthcare professionals worldwide. Metagenics entered into a strategic partnership with Alticor, an $8 billion global company with a shared commitment to innovative scientific research and development of quality products. Under the terms of the agreement entered into by the companies, Alticor acquired a substantial ownership interest in Metagenics and Bison sold its holdings.
Metagenics, Inc,
Metagenics, Inc. is a leading provider of medical foods and nutraceuticals to medical practitioners worldwide. Founded in 1983 and headquarterd in San Clemente, California, Metagenics’ goal is to help people achieve their genetic potential through nutrition.
The company currently sells over 400 all-natural, research-based products formulated to treat the chronic health problems associated with cardiovascular disease, inflammation, gastrointestinal disease and endocrine disorders. With over 400 employees worldwide, including a team of over 30 scientific specialists and clinicians, the company has built a reputation for providing products that meet the highest standards of safety, efficacy, and quality. Metagenics complies with the rigorous standards for Good Manufacturing Practices and is certified by the National Nutritional Foods Association, NSF International and the Therapeutic Goods Administration of Australia.
About Bison Capital
Bison Capital is a Los Angeles and New York based private equity firm that makes growth capital investments in middle‐market companies, public or private, for expansion, acquisitions, and balance sheet recapitalizations. The firm’s primary investment focus is partnering with entrepreneurs and management teams seeking capital to grow their businesses. www.bisoncapital.com
